With Study Group on Counterfeit Drugs to Resume Discussions this Fall, Full-Scale Discussions on Introduction of PIC/S GDP Guidelines Looming

By Tomoyuki Iwasaki The health ministry’s study group on counterfeit drugs will meet again this autumn. In its interim report announced in June , the study group noted that the establishment of domestic rules consistent with global PIC/S GDP guidelines...read more